Industry Roundup
This article was originally published in The Tan Sheet
Executive Summary
FDA warns eye supplement marketer; Kentucky age-restricts OTC DXM sales; FDA, EPA data-sharing pact; Colorado, Maine pass microbead laws; and more news in brief.
You may also be interested in...
Trade Groups Expand Caffeine Labeling To Stave Off Tighter Regs
The Council for Responsible Nutrition and the American Herbal Products Association amend guidelines and requirements for labeling and marketing caffeine-containing products, going beyond the law in response to congressional and public health complaints about the ingredient’s safety.
Execs On The Move: August 2023
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart
Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.